FDA WARNING
Ozempic, Wegovy face new labels over rare but permanent risk

FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss
The Food and Drug Administration now requires warning labels on Ozempic, Wegovy and other GLP-1 drugs over a rare eye condition tied to vision loss.










